JusticeItaly Official institution
Italy authorizes parallel import of medicine Travocort
Italy's medicines regulator AIFA has published a notice authorizing the parallel import of Travocort, a medicine for human use. A parallel import lets a medicine already approved in another country be brought into Italy and sold under a separate Italian permit. The excerpt does not give further details, which are in the source document.
This summary was generated by AI; the official source prevails.
What does it mean?
A medicine already sold in another country can now be brought into Italy and sold here under a separate Italian permit. The notice names Travocort, but the excerpt does not say who will import it or where it comes from.
Who is affected?
Patients in Italy who use Travocort and the companies that would import and sell it there.